Back

Biomarker release and haemolysis among three different pulsed field ablation strategies

30 March 2025 (16:42 - 16:51)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation ablation complications Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Ana Jordan

Clinical Hospital Dubrava, Zagreb (Croatia)

6 More presentations in this session

Presentation thumbnail
Trends in mortality over time in patients with oesophageal fistula post AF ablation: results from a worldwide FDA database - a subanalysis of the POTTER-AF 2 study
Doctor S. Popescu (Luebeck, DE)
Abstract Slides Video
Presentation thumbnail
PVI-induced periesophageal vagal nerve injury detected by Electrogastrography
Associate Professor D. Grosse Meininghaus (Cottbus, DE)
Abstract Slides Video
Presentation thumbnail
Hemolysis after pulsed field ablation in pulmonary vein isolation: a prospective controlled trial
Doctor C. auf der Heiden (Duesseldorf, DE)
Abstract Slides Video
Presentation thumbnail
Risk of mechanical or electrical complications with pulsed field ablation in patients with cardiac implantable electronic devices
Doctor A. Del Monte (Brussels, BE)
Abstract Slides Video
Presentation thumbnail
Evaluation of the impact of using a steerable sheath and bubble filters on the incidence of asymptomatic brain lesions following atrial fibrillation (AF) ablation
Miss B. Sanz Verdejo (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Atrial fibrillation ablation complications
Video

The Event

Event poster

EHRA 2025

30 March 2025 16:42 CET
You may be interested in
thumbnail
Congress Session
Atrial fibrillation: ablation 3
thumbnail
Congress Session
Pulsed field ablation for atrial fibrillation ablation: latest findings
thumbnail
Congress Presentation
Hemolysis after pulsed field ablation in pulmonary vein isolation: a prospective controlled trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources